Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 5, 2003, Pages 1022-1029

  Scorsin, Marcio ^a   Mebazaa, Alexandre ^a   Al Attar, Nawwar ^b   Medini, Betta ^b   Callebert, Jacques ^b   Raffoul, Richard ^b   Ramadan, Ramzi ^b   Maillet, Jean Michel ^b   Ruffenach, Alain ^b   Simoneau, François ^b   Nataf, Patrick ^b   Payen, Didier ^b   Lessana, Arrigo ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESMOLOL; GLUCOSE; LACTIC ACID; NITRIC OXIDE; POTASSIUM ION;

ADULT; AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CALCULATION; CARDIOPLEGIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; FEMALE; FLOW RATE; HEART HYPERTROPHY; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEMODYNAMICS; HUMAN; INTRACORONARY INFUSION; MALE; MEASUREMENT; OXIDATIVE STRESS; OXYGEN SATURATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0038012840     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.175     Document Type: Article

References (30)

1. Gay W. Crystalloid potassium cardioplegia: concepts and early studies. Ann Thorac Surg. 1994;58:1285-6.
2. Tyers G, Manley N, Williams E, Schaffer C, William D, Kurusz M. Preliminary clinical experience with isotonic hypothermic potassium induced arrest. J Thorac Cardiovasc Surg. 1977;74:674-81.
3. Kupriyanov V, Xiang B, Butler K, St-Jean M, Deslauriers R. Contractile dysfunction caused by normothermic ischemia and KCl arrest in the isolated pig heart: a 31P NMR study. J Mol Cell Cardiol. 1995;27:1715-30.
4. Handy J, Spinale F, Mukherjee R, Crawford F. Hypothermic potassium cardioplegia impairs myocyte recovery of contractility and inotropy. J Thorac Cardiovasc Surg. 1994;107:1050-8.
5. 2+ loading: insight into cardioprotection during cardioplegia. Ann Thorac Surg. 1998;65:586-91.
6. Kuhn-Régnier F, Natour E, Dhein S, Dapunt O, Geissler HJ, LaRose K, et al. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Cardiovasc Surg. 1999;15:67-74.
7. Mehlhorn U, Sauer H. Kuhn-Régnier F, Südkamp M, Dhein S, Eberhardt F, et al. Myocardial β-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg. 1999;7:549-57.
8. Ede M, Ye J, Gregorash L, Summers R, Pargaonkar S, LeHouerou D, et al. Beyond hyperkalemia: β-blocker-induced cardiac arrest for normothermic cardiac operations. Ann Thorac Surg. 1997;63:721-7.
9. Bessho R, Chambers D. Myocardial protection: the efficacy of an ultra-short-acting β-blocker, esmolol, as a cardioplegic agent. J Thorac Cardiovasc Surg. 2001;122:993-1003.
10. Warters RD, Allen SJ, Davis KL, Geisser HJ, Bischoff I EM, Mutschler E, et al. β-Blockade as an alternative to cardioplegic arrest during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:961-6.
11. Geissler HJ, Davis KL, Allen SJ, Buja LM, Laine GA, Mehlhorn U, et al. High-dose β-blockade during reperfusion only reduces ischemiareperfusion injury [abstract]. FASEB J. 1998;12:A4124.
12. Laub G, Muralidharan S, Reibman J, Fernandez J, Anderson W, Gu J, et al. Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model. J Thorac Cardiovasc Surg. 1996;111:1085-91.
13. Kandhoudi N, Percevault-Albadine J, Bril A. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury. J Cardiovasc Pharmacol. 1998;32:443-51.
14. Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol. 1985;56:40F-8F.
15. 1-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction. A double-blind, placebo-controlled, positron-emission tomography study. Circulation. 2000;102:2070-5.
16. Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM. Kinetics of esmolol, an ultra-short-acting β-blocker, and of its major metabolite. Clin Pharmacol Ther. 1983;34:427-34.
17. Devereux R, Alonso D, Lutas E, Gottlieb G, Campo E, Sachs Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.
18. Giovannoni G, Land J, Keir G, Thompson E, Heales S. Adaptation of nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem. 1997;34:193-8.
19. Laine H, Katoh C, Luotolahti M, Yki-Järvinen H, Kantola I, Jula A, et al. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation. 1999;100:2425-30.
20. Matter C, Mandinov L, Kaufman PA, Vassali G, Jiang Z, Hess OM. Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation. 1999;99:2396-401.
21. Salerno T, Houck J, Barrozo C, Panos A, Christakis G, Abel J, et al. Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg. 1991;51:245-7.
22. Caputo M, Ascione R, Angelini GD, Suleiman MS, Bryan AJ. The end of cold era: from intermittent cold to intermittent warm blood cardioplegia. Eur J Cardiothorac Surg. 1998;14:467-75.
23. Buckberg G, Brazier J, Nelson R, Goldstein S, McConnel D, Cooper N. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg. 1977;73:87-94.
24. Chambers DJ, Hearse DJ. Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest. Ann Thorac Surg. 1999;68:1960-6.
25. 2+ waves: a laser confocal microscopy study. Heart Circ Physiol. 1996;39:1384-9.
26. Caldarone C, Krukenkamp I, Misare B, Levitsky S. Perfusion deficits with retrograde warm blood cardioplegia. Ann Thorac Surg. 1994;57:403-6.
27. Partington M, Acar C, Buckberg G, Julia P, Kofsky E, Bugyi H. Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries. J Thorac Cardiovasc Surg. 1989;97:605-12.
28. Mebazaa A, Randall W, Cherian M, Abraham M. Comparison between endocardial and great vessel endothelial cells morphology, growth, and prostaglandin release. Am J Physiol. 1995;268:H250-9.
29. Davies P, Tripathi S. Mechanical stress mechanisms and the cell. An endothelial paradigm. Circ Res. 1993;1993:239-45.
30. Lanone S, Manivet P, Callebert J, Launay J, Payen D, Aubier M, et al. Inducible nitric oxide synthase (NOS-2) expressed in septic patients is nitrated on selective tyrosine residues: implications in enzymatic activities. Biochem J. 2002;366(Pt 2):399-404.